Literature DB >> 11226893

[Basal cell carcinoma of the vulva: 21 cases].

C Mateus1, M Fortier-Beaulieu, C Lhomme, F Rochard, D Castaigne, P Duvillard, M F Avril.   

Abstract

INTRODUCTION: Basal cell carcinoma (BCC) accounts for 2 to 3 p. 100 of all vulvar malignancies. PATIENTS AND METHODS: We report a retrospective study of 21 cases treated from 1937 to 1999.
RESULTS: Vulvar BCC's occurred in elderly patients (average age: 66 years), with mean delay to diagnosis of 5.5 years. Five patients were referred for recurrence. Lesions were located on the external hairy side of the labia majus, except one located on the internal side. In 4 cases a preexisting risk factor was identified: 2 patients had previously received radiation therapy and 2 other patients had multiple disseminated BCC. Mean BCC diameter was 2 cm. Pathological data were similar to skin BCC, with one case of mixed tumor (BCC and squamous cell carcinoma). The treatment was surgical excision for 19 BCCs. Local recurrence risk was high. Only one patient died of visceral dissemination of the disease. DISCUSSION: More than 250 cases of vulvar BCC have been reported in the literature. Clinical, pathological and follow up data are similar to results in the present series. Treatment of choice consists of surgical excision with tumor-free margins. Because of local recurrence risk and possible association with other primary cancers in this age group, long term follow-up is necessary.

Entities:  

Mesh:

Year:  2001        PMID: 11226893

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  2 in total

1.  Saved by step sections: an unusual presentation of basal cell carcinoma.

Authors:  Betina Werner; Fabiane Mulinari-Brenner
Journal:  Dermatol Pract Concept       Date:  2011-01-31

2.  Vulvar basal cell carcinoma: report of a case involving the mucosa and review of the literature.

Authors:  Marie Caucanas; Gebhard Müller; Olivier Vanhooteghem
Journal:  Dermatol Reports       Date:  2011-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.